- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- monomer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 16 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 3 residues within 4Å:- Chain A: K.184, I.187, D.188
Ligand excluded by PLIPEDO.4: 1 residues within 4Å:- Chain A: E.140
Ligand excluded by PLIPEDO.6: 2 residues within 4Å:- Chain A: F.133, R.272
Ligand excluded by PLIPEDO.7: 7 residues within 4Å:- Chain A: D.78, V.79, A.80, P.127, E.261, R.264, R.268
Ligand excluded by PLIPEDO.8: 7 residues within 4Å:- Chain A: L.97, T.100, W.306, V.310, D.313, A.314, I.317
Ligand excluded by PLIPEDO.9: 4 residues within 4Å:- Chain A: L.54, K.58, I.59, V.61
Ligand excluded by PLIPEDO.11: 5 residues within 4Å:- Chain A: L.110, K.177, Q.178, S.181
- Ligands: EDO.16
Ligand excluded by PLIPEDO.12: 4 residues within 4Å:- Chain A: F.160, F.171, R.179, R.183
Ligand excluded by PLIPEDO.13: 4 residues within 4Å:- Chain A: D.188, L.191, K.197, Q.233
Ligand excluded by PLIPEDO.14: 1 residues within 4Å:- Chain A: E.140
Ligand excluded by PLIPEDO.15: 5 residues within 4Å:- Chain A: N.37, A.77, N.83, N.84, I.85
Ligand excluded by PLIPEDO.16: 5 residues within 4Å:- Chain A: T.108, L.110, S.181, M.185
- Ligands: EDO.11
Ligand excluded by PLIPEDO.17: 6 residues within 4Å:- Chain A: R.252, V.287, E.288, W.327, Y.328, T.331
Ligand excluded by PLIPEDO.19: 2 residues within 4Å:- Chain A: K.161, Q.164
Ligand excluded by PLIPEDO.21: 1 residues within 4Å:- Chain A: Q.180
Ligand excluded by PLIPEDO.23: 3 residues within 4Å:- Chain A: T.70, H.74, E.165
Ligand excluded by PLIP- 2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 1 x PO4: PHOSPHATE ION(Non-functional Binders)
- 1 x JN4: ethenyl 6-(ethenylcarbamoyl)-2-[(phenylacetyl)amino]-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylate(Non-covalent)
JN4.20: 16 residues within 4Å:- Chain A: Y.81, M.195, L.241, N.243, P.244, Y.251, W.254, T.255, I.258, M.259, F.262, M.279, S.290, Q.291, F.294
- Ligands: PO4.18
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:Y.81, A:P.244, A:Y.251, A:I.258, A:F.294
- Hydrogen bonds: A:Q.291
- Water bridges: A:Y.81
- pi-Stacking: A:F.262, A:F.294
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nankervis, J.L. et al., Thiophene inhibitors of PDE4: Crystal structures show a second binding mode at the catalytic domain of PDE4D2. Bioorg.Med.Chem.Lett. (2011)
- Release Date
- 2011-10-26
- Peptides
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- monomer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 16 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 1 x PO4: PHOSPHATE ION(Non-functional Binders)
- 1 x JN4: ethenyl 6-(ethenylcarbamoyl)-2-[(phenylacetyl)amino]-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nankervis, J.L. et al., Thiophene inhibitors of PDE4: Crystal structures show a second binding mode at the catalytic domain of PDE4D2. Bioorg.Med.Chem.Lett. (2011)
- Release Date
- 2011-10-26
- Peptides
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A